Detalhe da pesquisa
1.
Hemophagocytic lymphohistiocytosis in an adolescent with NLRP12-related autoinflammatory disorder-A case report.
Pediatr Allergy Immunol
; 34(9): e14020, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37747755
2.
Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment.
Front Pediatr
; 11: 1200401, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37388286
3.
Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.
Front Immunol
; 13: 864674, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35677044
4.
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Lancet Infect Dis
; 21(5): 688-696, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428870
5.
Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom.
EBioMedicine
; 65: 103247, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647770
6.
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing.
Vaccine
; 38(49): 7834-7841, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33109390
7.
Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants.
Open Forum Infect Dis
; 7(5): ofaa143, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32494580
8.
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1â+â1) compared with two primary doses and a booster (2â+â1) in UK infants: a multicentre, parallel group randomised controlled trial.
Lancet Infect Dis
; 18(2): 171-179, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174323